Esan G J, Morgan F J, O'Donnell J V, Ford S, Bank A
J Clin Invest. 1970 Dec;49(12):2218-21. doi: 10.1172/JCI106440.
In patients heterozygous for abnormal hemoglobins there is usually less than 50% of the mutant hemoglobin present in peripheral blood. The synthetic rates of alpha-chain mutants compared to alpha(A) have not been reported to date. In this study the production of alpha(A)- and alpha(I)-chains has been measured in peripheral blood and bone marrow of two patients with approximately 30% hemoglobin I, an alpha-chain abnormality (alpha(16 lys --> glu)). The results suggest that the decreased amount of alpha(I) compared to alpha(A) is due solely to diminished biosynthesis of the alpha(I)-chains. The relative rates of synthesis of alpha(I)- and alpha(A)-chains are similar in both nucleated red cells and reticulocytes indicating that no change occurs during erythroid cell maturation which preferentially affects either alpha(I) or alpha(A) production.
在异常血红蛋白杂合子患者中,外周血中通常存在不到50%的突变血红蛋白。迄今为止,尚未报道α链突变体与α(A)相比的合成速率。在本研究中,对两名血红蛋白I含量约为30%(一种α链异常,α(16赖氨酸→谷氨酸))的患者的外周血和骨髓中α(A)链和α(I)链的产生情况进行了测量。结果表明,与α(A)相比,α(I)含量降低完全是由于α(I)链生物合成减少所致。α(I)链和α(A)链的相对合成速率在有核红细胞和网织红细胞中相似,这表明在红系细胞成熟过程中没有发生优先影响α(I)或α(A)产生的变化。